<?xml version="1.0" encoding="utf-8"?> <rss version="2.0"> <channel xmlns:dc="http://dublincore.org/documents/dcmi-namespace/" xmlns:media="http://search.yahoo.com/mrss/"> <title>Biosenta Inc</title> <link>https://www.globenewswire.com/rssfeed/organization/-x6e-FknfauzsnlecYRsqQ==</link> <description>Contains the last 20 releases</description> <copyright>Copyright 2023, Biosenta Inc</copyright> <managingEditor>newsdesk@globenewswire.com (NewsDesk)</managingEditor> <lastBuildDate>Thu, 28 Sep 2023 21:19:04 GMT</lastBuildDate> <webMaster>webmaster@globenewswire.com (Webmaster)</webMaster> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/09/28/2751673/0/en/Biosenta-Announces-Breakthrough-Discovery-in-Anti-Microbial-Efficacy-of-Tri-Filler-in-Collaboration-with-Dr-Ian-Lewis-and-Dr-Maen-Husein-s-Labs.html</guid> <link>https://www.globenewswire.com/news-release/2023/09/28/2751673/0/en/Biosenta-Announces-Breakthrough-Discovery-in-Anti-Microbial-Efficacy-of-Tri-Filler-in-Collaboration-with-Dr-Ian-Lewis-and-Dr-Maen-Husein-s-Labs.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs</title> <description><![CDATA[<p align="justify">TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is thrilled to announce a pivotal discovery led by Dr. Mehdi Mohammadi Ashani, a Postdoctoral Researcher under the mentorship of Dr. Ian Lewis and Dr. Maen Husein at the University of Calgary. Utilizing the advanced capabilities of the Alberta Centre for Advanced Diagnostics (ACAD), this research has revealed that Tri-Filler™, our flagship product, effectively sterilizes a wide range of microorganisms including:<br></p>]]></description> <pubDate>Thu, 28 Sep 2023 21:19 GMT</pubDate> <dc:identifier>2751673</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Thu, 28 Sep 2023 21:19 GMT</dc:modified> <dc:subject>Product / Services Announcement</dc:subject> <dc:subject>Research Analysis and Reports</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/09/06/2738595/0/en/Biosenta-builds-on-partnership-with-AMPAK-to-test-and-commercialize-Tri-Filler.html</guid> <link>https://www.globenewswire.com/news-release/2023/09/06/2738595/0/en/Biosenta-builds-on-partnership-with-AMPAK-to-test-and-commercialize-Tri-Filler.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CSE (CSE: ZRO) is pleased to announce the next level of partnership with AMPAK Inc. and the University of Calgary. The new Agreement will see Tri-Filler™ being tested in plastics at AMPAK Inc. facilities with an eye to commercialization.<br></p>]]></description> <pubDate>Wed, 06 Sep 2023 14:07 GMT</pubDate> <dc:identifier>2738595</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Wed, 06 Sep 2023 14:08 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/08/08/2721077/0/en/Biosenta-announces-further-advances-in-research-and-development-of-Tri-Filler.html</guid> <link>https://www.globenewswire.com/news-release/2023/08/08/2721077/0/en/Biosenta-announces-further-advances-in-research-and-development-of-Tri-Filler.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta announces further advances in research and development of Tri-Filler™</title> <description><![CDATA[<p align="justify">TORONTO and CALGARY, Alberta, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO) is pleased to announce further advances in research and development of the Tri-Filler™ particle composed of Ca(OH)<sub>2</sub> (calcium hydroxide) core with a CaCO<sub>3</sub> (calcium carbonate) encapsulation. Ongoing development of new methods of production of Tri-Filler™ by Dr. Maen Husein of the Department of Chemical Engineering at the University of Calgary and his team have reduced aggregation and resulted in the production of Tri-Filler™ particles being more uniform in shape and morphology. Additionally, using these new production methods, Tri-Filler™ can now be produced continuously at a higher rate than previously achieved.<br></p>]]></description> <pubDate>Tue, 08 Aug 2023 20:00 GMT</pubDate> <dc:identifier>2721077</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Tue, 08 Aug 2023 20:01 GMT</dc:modified> <dc:subject>Product / Services Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/07/17/2705510/0/en/Biosenta-Announces-Termination-of-Joint-Venture-and-Issuance-of-Securities.html</guid> <link>https://www.globenewswire.com/news-release/2023/07/17/2705510/0/en/Biosenta-Announces-Termination-of-Joint-Venture-and-Issuance-of-Securities.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Termination of Joint Venture and Issuance of Securities</title> <description><![CDATA[<p align="justify">TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “<strong>Company</strong>” or “<strong>Biosenta</strong>”) (CSE: ZRO) is pleased to announce that it has completed its previously announced transaction to terminate its joint venture agreement between the Company and 19443391 Ontario Inc. (“<strong>194</strong>”) pursuant to a termination of joint venture agreement dated June 23, 2023 (the “<strong>Termination Agreement</strong>”) and issue to 194 3,000,000 common shares of the Company at a deemed issue price of $0.40 per share and a promissory note in the amount of $6,500,000 (the “<strong>Note</strong>”) as consideration (the “<strong>Transaction</strong>”).<br></p>]]></description> <pubDate>Mon, 17 Jul 2023 11:20 GMT</pubDate> <dc:identifier>2705510</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Mon, 17 Jul 2023 11:21 GMT</dc:modified> <dc:subject>Business Contracts</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/06/23/2693927/0/en/Biosenta-Announces-Entering-Into-of-Agreement-to-Terminate-Joint-Venture.html</guid> <link>https://www.globenewswire.com/news-release/2023/06/23/2693927/0/en/Biosenta-Announces-Entering-Into-of-Agreement-to-Terminate-Joint-Venture.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Entering Into of Agreement to Terminate Joint Venture </title> <description><![CDATA[<p align="justify">TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “<strong>Company</strong>” or “<strong>Biosenta</strong>”) (CSE: ZRO) is pleased to announce that it has come to an agreement (the “<strong>Agreement</strong>”) with 19443391 Ontario Inc. (“<strong>194</strong>”) and its shareholders to terminate the existing joint venture agreement (the “<strong>JV Agreement</strong>”) between the Company and 194 and issue certain securities as consideration (the “<strong>Transaction</strong>”). As 194 is considered a “related party” to Biosenta (as such term is defined in Multilateral Instrument 61-101 <em>Protection of Minority Security Holders in Special Transactions </em>(“<strong>MI 61-101</strong>”), the Transaction is considered a “related party transaction” within the meaning of MI 61-101.<br></p>]]></description> <pubDate>Fri, 23 Jun 2023 21:01 GMT</pubDate> <dc:identifier>2693927</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Fri, 23 Jun 2023 21:01 GMT</dc:modified> <dc:subject>Business Contracts</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2023/05/31/2679885/0/en/Biosenta-Inc-ceases-negotiations-with-Voran-Group-Ventures-Ltd.html</guid> <link>https://www.globenewswire.com/news-release/2023/05/31/2679885/0/en/Biosenta-Inc-ceases-negotiations-with-Voran-Group-Ventures-Ltd.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, May 31, 2023 (GLOBE NEWSWIRE) -- <strong>Biosenta Inc. ( “Biosenta”) (CSE: ZRO) </strong>announces that, further to its news release dated October 12, 2022, it has ceased negotiations with Voran Group Ventures Ltd. in respect of the previously announced Memorandum of Understanding dated October 5, 2022, for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide.<br></p>]]></description> <pubDate>Wed, 31 May 2023 22:32 GMT</pubDate> <dc:identifier>2679885</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Wed, 31 May 2023 22:32 GMT</dc:modified> <dc:subject>Other News</dc:subject> <dc:subject>Stock Market News</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2022/10/12/2533243/0/en/Biosenta-Inc-Enters-into-an-MOU-with-Voran-Group-Ventures-Ltd-to-collaborate-on-the-commercialization-of-Biosenta-s-Tri-Filler-Products.html</guid> <link>https://www.globenewswire.com/news-release/2022/10/12/2533243/0/en/Biosenta-Inc-Enters-into-an-MOU-with-Voran-Group-Ventures-Ltd-to-collaborate-on-the-commercialization-of-Biosenta-s-Tri-Filler-Products.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Inc. Enters into an MOU with Voran Group Ventures Ltd. to collaborate on the commercialization of Biosenta’s Tri-Filler® Products</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, Oct. 12, 2022 (GLOBE NEWSWIRE) -- <strong>Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO)</strong> has signed a milestone Memorandum of Understanding dated October 5, 2022, with VORAN GROUP VENTURES Ltd. (“Voran”) which will lead the way for the commercialization of Biosenta’s Tri-Filler® antimicrobial products in Canadian markets and worldwide.<br></p>]]></description> <pubDate>Wed, 12 Oct 2022 16:11 GMT</pubDate> <dc:identifier>2533243</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Wed, 12 Oct 2022 16:12 GMT</dc:modified> <dc:subject>Partnerships</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2022/05/25/2450672/0/en/University-of-Calgary-research-on-Biosenta-filler-particles-yields-very-encouraging-results-for-the-construction-industry-in-the-fight-against-bacteria.html</guid> <link>https://www.globenewswire.com/news-release/2022/05/25/2450672/0/en/University-of-Calgary-research-on-Biosenta-filler-particles-yields-very-encouraging-results-for-the-construction-industry-in-the-fight-against-bacteria.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>University of Calgary research on Biosenta filler particles yields very encouraging results for the construction industry in the fight against bacteria</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, May 25, 2022 (GLOBE NEWSWIRE) -- Biosenta Inc. (the “Company” or “Biosenta”) (CSE: ZRO) is developing environmentally friendly biocidal particles that are successfully tested against infectious bacteria growing on common surfaces. The particles are developed in collaboration with Dr. Maen Husein’s laboratory, University of Calgary, and tested in Dr. Ian Lewis’s laboratory, University of Calgary. Preliminary results showed that inclusion of the particles into cement provides effective biocidal attributes.<br></p>]]></description> <pubDate>Wed, 25 May 2022 17:12 GMT</pubDate> <dc:identifier>2450672</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Wed, 25 May 2022 17:13 GMT</dc:modified> <dc:subject>Health</dc:subject> <dc:subject>Pre-Release Comments</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2021/01/28/2166196/0/en/Biosenta-Announces-Note-Financing.html</guid> <link>https://www.globenewswire.com/news-release/2021/01/28/2166196/0/en/Biosenta-Announces-Note-Financing.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Note Financing</title> <description><![CDATA[<p align="justify">TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biosenta Inc. (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CSE (CSE:ZRO) announces that it will enter into a series of prime plus 5% unsecured promissory notes (the “<strong>Notes</strong>”) in consideration for cash investments in the aggregate amount of $85,000 (together, the “<strong>Investment</strong>”). The Investment will provide capital for Biosenta to meet the financial requirements of its day-to-day operations and to continue its strategic business plan to grow the company and to capture the growing trend for safe, consumer, commercial and industrial disinfectant with anti-microbial compounds.<br></p>]]></description> <pubDate>Thu, 28 Jan 2021 19:14 GMT</pubDate> <dc:identifier>2166196</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Thu, 28 Jan 2021 19:14 GMT</dc:modified> <dc:subject>Financing Agreements</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2021/01/26/2164758/0/en/Biosenta-Announces-Record-Revenues.html</guid> <link>https://www.globenewswire.com/news-release/2021/01/26/2164758/0/en/Biosenta-Announces-Record-Revenues.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Record Revenues</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is for an initial order of 145 drums (30,160 litres) of TRUE disinfectant and continued monthly orders.<br></p>]]></description> <pubDate>Tue, 26 Jan 2021 23:29 GMT</pubDate> <dc:identifier>2164758</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Tue, 26 Jan 2021 23:29 GMT</dc:modified> <dc:subject>Product / Services Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/12/22/2149564/0/en/U-S-Partner-Secures-Licensing-Rights-to-2-400-Retail-Stores.html</guid> <link>https://www.globenewswire.com/news-release/2020/12/22/2149564/0/en/U-S-Partner-Secures-Licensing-Rights-to-2-400-Retail-Stores.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>U.S. Partner Secures Licensing Rights to 2,400 Retail Stores</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) -- On December 21, 2020 Biosenta’s U.S. licensing partner Kleen Bee Labs, LLC has secured licensing rights in Ralphs and Food 4 Less retailers, which are divisions of Kroger Corp. Kroger Corp is one of the largest retailers in the US with approx. 2,400 stores. Kleen Bee Labs long term goal is to distribute in over 10,000 stores across the United States.<br></p>]]></description> <pubDate>Tue, 22 Dec 2020 15:27 GMT</pubDate> <dc:identifier>2149564</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Tue, 22 Dec 2020 15:27 GMT</dc:modified> <dc:subject>Partnerships</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/12/17/2147109/0/en/Biosenta-growth-milestone.html</guid> <link>https://www.globenewswire.com/news-release/2020/12/17/2147109/0/en/Biosenta-growth-milestone.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta growth milestone</title> <description><![CDATA[<p align="justify">CALGARY, Alberta, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This marked the third day of Alberta’s Province wide Covid-19 lockdown. This is in step with Biosenta’s strategic business plan grow the company and to capture the growing trend for safe, consumer, commercial and industrial disinfectant with anti-microbial compounds. This comes on the eve of Biosenta receiving the patent for Canada.<br></p>]]></description> <pubDate>Thu, 17 Dec 2020 14:26 GMT</pubDate> <dc:identifier>2147109</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Thu, 17 Dec 2020 14:26 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/09/24/2099024/0/en/Biosenta-and-University-of-Calgary-Research-Group-launch-anti-microbial-nanoparticle-development-partnership.html</guid> <link>https://www.globenewswire.com/news-release/2020/09/24/2099024/0/en/Biosenta-and-University-of-Calgary-Research-Group-launch-anti-microbial-nanoparticle-development-partnership.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta and University of Calgary Research Group launch anti-microbial, nanoparticle development partnership</title> <description><![CDATA[<p align="justify">TORONTO, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CSE (CSE: ZRO) is pleased to announce the finalization of a four-year research partnership with the University of Calgary.<br></p>]]></description> <pubDate>Thu, 24 Sep 2020 21:07 GMT</pubDate> <dc:identifier>2099024</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Thu, 24 Sep 2020 21:06 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/09/14/2093292/0/en/Biosenta-Announces-Royalty-License-Agreement-for-North-American-Distribution.html</guid> <link>https://www.globenewswire.com/news-release/2020/09/14/2093292/0/en/Biosenta-Announces-Royalty-License-Agreement-for-North-American-Distribution.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Royalty License Agreement for North American Distribution</title> <description><![CDATA[<p align="justify">TORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. ("<strong>Biosenta</strong>" or the "<strong>Company</strong>") listed on the CSE (CSE:ZRO) is pleased to announce - A strategic licensing partnership with Kleen Bee Labs was finalized today. This license will give the rights for distribution of DualXtiv, a broad-spectrum anti-microbial disinfectant, to club level, mass grocery, and retail chains across North America.<br></p>]]></description> <pubDate>Mon, 14 Sep 2020 20:58 GMT</pubDate> <dc:identifier>2093292</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Mon, 14 Sep 2020 20:57 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Health</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/09/09/2090941/0/en/Biosenta-Announces-launching-true-in-North-America.html</guid> <link>https://www.globenewswire.com/news-release/2020/09/09/2090941/0/en/Biosenta-Announces-launching-true-in-North-America.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces launching true™ in North America</title> <description><![CDATA[<p align="justify">TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CSE (CSE:ZRO) is pleased to announce - Biosenta is launching a dual-action, broad-spectrum anti-microbial disinfectant to combat COVID-19 in North America. <br></p>]]></description> <pubDate>Wed, 09 Sep 2020 12:30 GMT</pubDate> <dc:identifier>2090941</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Wed, 09 Sep 2020 12:30 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> <dc:subject>Product / Services Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/06/23/2052272/0/en/Biosenta-Announces-its-First-Sale-of-Product-True-in-Canada.html</guid> <link>https://www.globenewswire.com/news-release/2020/06/23/2052272/0/en/Biosenta-Announces-its-First-Sale-of-Product-True-in-Canada.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces its First Sale of Product “True” in Canada</title> <description><![CDATA[<p align="justify">TORONTO, June 23, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc. (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CNSX (CNSX:ZRO) is pleased to announce it is launching its disinfectant product called “True” in Canada. Originally our product was filed with the trademark “Erase” but we received approval for a name change to “TRUE” to be consistent with the name of Biosenta’s disinfectant previously launched in the US.<br></p>]]></description> <pubDate>Tue, 23 Jun 2020 18:24 GMT</pubDate> <dc:identifier>2052272</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Tue, 23 Jun 2020 18:23 GMT</dc:modified> <dc:subject>Product / Services Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2020/04/02/2010414/0/en/Biosenta-Announces-its-First-Sale-of-Product-True-in-the-U-S.html</guid> <link>https://www.globenewswire.com/news-release/2020/04/02/2010414/0/en/Biosenta-Announces-its-First-Sale-of-Product-True-in-the-U-S.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces its First Sale of Product “True” in the U.S.</title> <description><![CDATA[<p align="justify">TORONTO, April 01, 2020 (GLOBE NEWSWIRE) -- Biosenta Inc., (“<strong>Biosenta</strong>” or the “<strong>Company</strong>”) listed on the CNSX (CNSX:ZRO), is pleased to announce its first purchase order for its disinfectant product called “True” in the United States. <br></p>]]></description> <pubDate>Thu, 02 Apr 2020 01:08 GMT</pubDate> <dc:identifier>2010414</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Thu, 02 Apr 2020 01:07 GMT</dc:modified> <dc:subject>Product / Services Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/10/15/1621372/0/en/Biosenta-Announces-Signing-Marketing-Agreement-for-its-high-potency-Disinfectant.html</guid> <link>https://www.globenewswire.com/news-release/2018/10/15/1621372/0/en/Biosenta-Announces-Signing-Marketing-Agreement-for-its-high-potency-Disinfectant.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Signing Marketing Agreement for its high potency Disinfectant</title> <description><![CDATA[<p align="justify">TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (Biosenta) announces that it has signed an agreement with F&M Merchant Group LLC (F&M) to launch its disinfectant, named “True,” in the U.S. market.<br></p>]]></description> <pubDate>Mon, 15 Oct 2018 14:58 GMT</pubDate> <dc:identifier>1621372</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Mon, 15 Oct 2018 14:58 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/08/27/1557158/0/en/Biosenta-Announces-Signing-Exclusive-Global-Royalty-Agreement.html</guid> <link>https://www.globenewswire.com/news-release/2018/08/27/1557158/0/en/Biosenta-Announces-Signing-Exclusive-Global-Royalty-Agreement.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Signing Exclusive Global Royalty Agreement</title> <description><![CDATA[<p align="justify">TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Biosenta Inc. (CSE: ZRO) is pleased to announce, in conjunction with Microbial Research Products, the Joint Venture (JV) Agreement announced on February 28, 2018, it has signed its first Royalty Agreement for its Tri-Filler patented technology with Polski Bazalt / STM Technology (STM).<br></p>]]></description> <pubDate>Mon, 27 Aug 2018 18:40 GMT</pubDate> <dc:identifier>1557158</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc</dc:contributor> <dc:modified>Mon, 27 Aug 2018 18:40 GMT</dc:modified> <dc:subject>Company Announcement</dc:subject> </item> <item> <guid isPermaLink="true">https://www.globenewswire.com/news-release/2018/02/28/1419540/0/en/Biosenta-Announces-Joint-Venture-Agreement.html</guid> <link>https://www.globenewswire.com/news-release/2018/02/28/1419540/0/en/Biosenta-Announces-Joint-Venture-Agreement.html</link> <category domain="https://www.globenewswire.com/rss/stock">CNSX:ZRO.CN</category> <category domain="https://www.globenewswire.com/rss/ISIN">CA09072N2023</category> <title>Biosenta Announces Joint Venture Agreement</title> <description><![CDATA[<p style="
 text-align:left;
 ">TORONTO, ONTARIO--(Marketwired - Feb. 28, 2018) - Biosenta Inc. (CSE:ZRO)(CSE:ZRO.CN)(CNSX:ZRO) announces today that it has signed a five year Joint Venture (JV) agreement with investors to develop, market, and potentially grow the sales of its patented dry product, Tri-Filler.</p>]]></description> <pubDate>Wed, 28 Feb 2018 17:04 GMT</pubDate> <dc:identifier>1419540</dc:identifier> <dc:language>en</dc:language> <dc:publisher>GlobeNewswire Inc.</dc:publisher> <dc:contributor>Biosenta Inc.</dc:contributor> <dc:modified>Fri, 09 Mar 2018 03:40 GMT</dc:modified> </item> </channel> </rss>